pentamidine has been researched along with Cancer of Endometrium in 1 studies
Pentamidine: Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
pentamidine : A diether consisting of pentane-1,5-diol in which both hydroxyl hydrogens have been replaced by 4-amidinophenyl groups. A trypanocidal drug that is used for treatment of cutaneous leishmaniasis and Chagas disease.
Excerpt | Relevance | Reference |
---|---|---|
"Pentamidine has been reported to have many pharmacological effects including anti- protozoal, anti-inflammatory, and anti-tumor activities." | 1.72 | Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway. ( Gao, Y; Hu, X; Lin, L; Liu, C; Ouyang, J, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Lin, L | 3 |
Gao, Y | 3 |
Hu, X | 3 |
Ouyang, J | 3 |
Liu, C | 3 |
1 other study available for pentamidine and Cancer of Endometrium
Article | Year |
---|---|
Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway.
Topics: Cell Proliferation; Endometrial Neoplasms; Female; Humans; Matrix Metalloproteinase 2; Matrix Metall | 2022 |
Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway.
Topics: Cell Proliferation; Endometrial Neoplasms; Female; Humans; Matrix Metalloproteinase 2; Matrix Metall | 2022 |
Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway.
Topics: Cell Proliferation; Endometrial Neoplasms; Female; Humans; Matrix Metalloproteinase 2; Matrix Metall | 2022 |
Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway.
Topics: Cell Proliferation; Endometrial Neoplasms; Female; Humans; Matrix Metalloproteinase 2; Matrix Metall | 2022 |
Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway.
Topics: Cell Proliferation; Endometrial Neoplasms; Female; Humans; Matrix Metalloproteinase 2; Matrix Metall | 2022 |
Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway.
Topics: Cell Proliferation; Endometrial Neoplasms; Female; Humans; Matrix Metalloproteinase 2; Matrix Metall | 2022 |
Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway.
Topics: Cell Proliferation; Endometrial Neoplasms; Female; Humans; Matrix Metalloproteinase 2; Matrix Metall | 2022 |
Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway.
Topics: Cell Proliferation; Endometrial Neoplasms; Female; Humans; Matrix Metalloproteinase 2; Matrix Metall | 2022 |
Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway.
Topics: Cell Proliferation; Endometrial Neoplasms; Female; Humans; Matrix Metalloproteinase 2; Matrix Metall | 2022 |